Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • AstraZeneca  announced the top-line results of the SOCRATES trial, assessing the efficacy of Brilinta/Brilique (ticagrelor) 90mg tablets twice daily, when compared to aspirin 100mg once daily in patients with acute ischaemic stroke or transient ischaemic attack (TIA). The primary efficacy endpoint of time to first occurrence of any event from the composite of stroke (ischaemic or haemorrhagic), myocardial infarction (MI, also known as heart attack) and death was not met. Fewer events were observed on Brilinta/Brilique versus the comparator in the overall trial population but the trend did not reach statistical significance.

  • Janssen Research & Development, LLC announced it has entered into a clinical trial collaboration agreement with Genentech, a member of the Roche Group, to initiate two studies to determine the safety and tolerability of daratumumab (DARZALEX®), the first CD38-directed monoclonal antibody (mAb), in combination with atezolizumab, an investigational mAb designed to bind with a protein called programmed cell death-ligand 1 (PD-L1).

  • Teva Pharmaceutical Industries Ltd., announced the launch of the generic equivalent to CAMPRAL®1 (acamprosate calcium) delayed-release tablets, 333 mg, in the United States. Acamprosate calcium delayed-release tablets are used for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at the start of treatment.

  • Malaria, a life-threatening disease caused by parasites that are transmitted to people through mosquitoe bites, started out as a parasite in birds, and then it evolved to colonise bats, and from there it has evolved to affect other mammals, reveals a new study.

  • The Reston virus, a member of the Ebola virus family which is known to circulate in domestic pigs in Asia, may acquire the few mutations necessary to cause disease in humans and to develop into a novel health threat, researchers have warned.

  • With the government announcing eradication of tuberculosis by 2030, a doctor has says a new 'Endobroncial Ultrasound' medical process that was introduced in India recently can contribute in faster diagnosis of the disease leading to correct treatment on time.

Subscribe to Pharma News